Abattis Provides Update on Trading Halt and Corporate Developments

Nov 8, 2019    |    Abattis Bioceuticals
VANCOUVER, BRITISH COLUMBIA / Nov 8th, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) November 8, 2019 / Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company’s common shares on the Canadian Stock Exchange (the “CSE”) was halted on February 4, 2019 (the “Halt”).